10.2  2.18 (27.18%)		07-19 00:00
Open: 8.18 High: 12.58 Volume: 17,319,220		Pre. Close: 8.02 Low: 8.07 Market Cap: 1,479(M)

Short term
Mid term
Targets	6-month :	30.31	1-year :	31.93
Resists	First :	25.95	Second :	27.34
Pivot price	26.08
Supports	First :	23.71	Second :	19.73
MAs	MA(5) :	25.22	MA(20) :	25.77
	MA(100) :	23.71	MA(250) :	21.95
MACD	MACD :	0.2	Signal :	0.5
%K %D	K(14,3) :	11	D(3) :	19.1
RSI	RSI(14): 46.5
52-week	High :	27.34	Low :	19.04

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ GXG ] has closed above bottom band by 16.7%. Bollinger Bands are 71.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 13 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	25.24 - 25.41	25.41 - 25.56
Low:	24.14 - 24.35	24.35 - 24.54
Close:	24.7 - 25.04	25.04 - 25.34

GX Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is not engaged in any business operations and it has not generated any revenue.

Sat, 24 Jun 2023
(SPAC) Special Purpose Acquisition Investigation: FFIE, NRGV, CELU, Contact Shareholder Rights Law Firm Johnson ... - GlobeNewswire

Mon, 15 May 2023
Genting-backed biotech firm to get new investor - The Edge Malaysia

Fri, 13 Aug 2021
Shorting De-SPACs Could be the Play - TheStreet

Fri, 16 Jul 2021
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update - GlobeNewswire

Wed, 14 Jul 2021
What's Celularity's Forecast After the GXGX Merger? - Market Realist

Thu, 01 Jul 2021
Celularity and Arthrex Enter into Exclusive Supply and Distribution Agreement for Multiple Commercial Products - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.